- Home
- PRPO vs ZCMD Comparison
PRPO vs ZCMD Comparison
Compare PRPO & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- ZCMD
- Stock Information
- Founded
- PRPO N/A
- ZCMD 2012
- Country
- PRPO United States
- ZCMD China
- Employees
- PRPO N/A
- ZCMD N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- ZCMD Other Consumer Services
- Sector
- PRPO Industrials
- ZCMD Real Estate
- Exchange
- PRPO Nasdaq
- ZCMD Nasdaq
- Market Cap
- PRPO 22.0M
- ZCMD 25.3M
- IPO Year
- PRPO N/A
- ZCMD 2020
- Fundamental
- Price
- PRPO $15.41
- ZCMD $0.96
- Analyst Decision
- PRPO
- ZCMD
- Analyst Count
- PRPO 0
- ZCMD 0
- Target Price
- PRPO N/A
- ZCMD N/A
- AVG Volume (30 Days)
- PRPO 10.3K
- ZCMD 3.9K
- Earning Date
- PRPO 08-13-2025
- ZCMD 01-01-0001
- Dividend Yield
- PRPO N/A
- ZCMD N/A
- EPS Growth
- PRPO N/A
- ZCMD N/A
- EPS
- PRPO N/A
- ZCMD N/A
- Revenue
- PRPO $21,242,000.00
- ZCMD $15,864,773.00
- Revenue This Year
- PRPO N/A
- ZCMD N/A
- Revenue Next Year
- PRPO N/A
- ZCMD N/A
- P/E Ratio
- PRPO N/A
- ZCMD N/A
- Revenue Growth
- PRPO 27.05
- ZCMD N/A
- 52 Week Low
- PRPO $3.90
- ZCMD $0.86
- 52 Week High
- PRPO $16.89
- ZCMD $2.97
- Technical
- Relative Strength Index (RSI)
- PRPO 69.89
- ZCMD 46.85
- Support Level
- PRPO $14.04
- ZCMD $0.93
- Resistance Level
- PRPO $16.27
- ZCMD $1.07
- Average True Range (ATR)
- PRPO 0.64
- ZCMD 0.08
- MACD
- PRPO 0.10
- ZCMD 0.01
- Stochastic Oscillator
- PRPO 84.48
- ZCMD 47.62
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.